Determining the appropriate retatrutide amount is vitally essential for obtaining best outcomes . Initially, patients typically begin with a modest amount of around 2.4 mg, provided each week via subcutaneous . This preliminary amount is then incrementally increased every four periods, up to a maximum dose of 10.8 mg, according to person response